Sfoglia per Autore
HIV INFECTION AMONG ADOLESCENTS AND YOUNG ADULTS IN ITALY: EPIDEMIOLOGY, VIRO-IMMUNOLOGICAL AND TREATMENT OUTCOMES
2026 Fusco, F; Mastrorosa, I; Vichi, F; Cervo, A; Saracino, A; Calza, L; Quiros-Roldan, E; Elisabetta Teti, M; Costantini, A; Cingolani, A; Girardi, E; Antinori, A; D'Arminio Monforte, A; Tavelli, A; Bonfanti, P
Safety and durability of treatment with Bictegravir/Emtricitabine/Tenofovir Alafenamide in a real-life cohort
2025 Squillace, N; Ricci, E; Maggi, P; Taramasso, L; Menzaghi, B; Sarchi, E; De Socio, G; Piconi, S; Pellicanò, G; Bini, T; Madeddu, G; Martini, S; Pontali, E; Cenderello, G; Bandera, A; Celesia, B; Orofino, G; Ferrara, S; Carleo, M; Cascio, A; Di Biagio, A; Bonfanti, P
Potential for replacing protease inhibitor with doravirine in cART-experienced subjects successfully treated with darunavir-cobicistat plus dolutegravir dual regimen
2025 Ripamonti, D; Comi, L; Francavilla, A; Valenti, D; Cossu, M; Moschese, D; Lapadula, G; Mezzadri, L; Bonfanti, P; Mazzitelli, M; Cattelan, A; Gulminetti, R; Pagnucco, L; Fabbiani, M; Bini, T; Zazzi, M; Giacomelli, A
Sexual satisfaction in men with HIV aged ≤50 years explored with standardized validated questionnaires: prevalence and patterns of various sexual dysfunction, and association with psychosocial factors
2025 Squillace, N; Cogliandro, V; Brogna, V; Bernasconi, D; Bani, M; Rampoldi, G; Lapadula, G; Soria, A; Strepparava, M; Menzaghi, B; Bini, T; Piconi, S; Rochira, V; Bonfanti, P
Weight gain and metabolic complications in a large cohort of overweight and obese people with HIV.
2025 Taramasso, L; Ricci, E; Squillace, N; Costacurta, L; Orofino, G; Pellicanò, G; De Socio, G; Menzaghi, B; Ferrara, S; Maggi, P; Pontali, E; Piconi, S; Sarchi, E; Madeddu, G; Carleo, A; Martini, S; Salomoni, E; Bini, T; Cenderello, G; Celesia, B; Gulminetti, R; Bargiacchi, O; Cascio, A; Falasca, K; Lagi, F; Bonfanti, P; Di Biagio, A
Late-Onset Combined Immunodeficiency presenting with Progressive Multifocal Leukoencephalopathy and associated Immune Reconstitution Inflammatory Syndrome
2025 Mezzadri, L; Borghesi, M; Comoli, P; Pozzi, M; Lapadula, G; Rossi, M; Bonfanti, P
Persisting or recurrent dermatological manifestations in Long-COVID: Data from a national cohort of 1741 patients from Italy
2025 Floridia, M; Pagnanelli, G; Piccinni, G; Weimer, L; Onder, G; Bonfanti, P
Changing clinical and laboratory characteristics of Progressive Multifocal Leukoencephalopathy: a retrospective national cohort study
2025 Mainardi, I; Gerevini, S; Tarantino, A; Vercesi, R; Catalano, G; Garcia Martearena, M; Negri, M; Vezzulli, P; Bestetti, A; Moiola, L; Boschini, A; Calcagno, A; Del Bono, L; Gallo, A; Mena, M; Moioli, M; Castagna, A; Filippi, M; Lazzarin, A; Cinque, P; Bonfanti, P
Neuropsychiatric adverse events in people with HIV initiating a new integrase strand transfer inhibitor-based regimen in Italy: findings from the NEURO-INSTI study
2025 Squillace, N; Ricci, E; Orofino, G; Forcina, G; Albini, L; Menzaghi, B; De Socio, G; Piconi, S; Maggi, P; Madeddu, G; Pellicanò, G; Sarchi, E; Celesia, B; Lagi, F; Salomoni, E; Di Biagio, A; Bonfanti, P
Hepatitis B core antibody positivity is not associated with risk of transaminase elevation following switch to dual antiretroviral therapy
2025 Mezzadri, L; Soria, A; Ranzani, A; Malandrin, S; Sabbatini, F; Limonta, S; Cappelletti, A; Colella, E; Squillace, N; Caramma, I; Monti, B; Rugova, A; Cavallero, A; Bonfanti, P; Lapadula, G
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced disease: a trial emulation
2025 Gagliardini, R; Giacomelli, A; Mussini, C; Cole, S; Edwards, J; Pinnetti, C; Raimondi, A; Antinori, S; Nozza, S; Mazzotta, V; Marchetti, G; Caputo, S; Tavelli, A; Monforte, A; Antinori, A; Cozzi-Lepri, A; d'Arminio Monforte, A; Antinori, A; Antinori, S; Castagna, A; Cauda, R; Di Perri, G; Girardi, E; Iardino, R; Lazzarin, A; Marchetti, G; Mussini, C; Quiros-Roldan, E; Sarmati, L; Suligoi, B; von Schloesser, F; Viale, P; Ceccherini-Silberstein, F; Cingolani, A; Cozzi-Lepri, A; Di Biagio, A; Gori, A; Lo Caputo, S; Marchetti, G; Maggiolo, F; Puoti, M; Perno, C; Torti, C; Bandera, A; Bonora, S; Calcagno, A; Canetti, D; Cervo, A; Cinque, P; Gagliardini, R; Giacomelli, A; Gianotti, N; Guaraldi, G; Lanini, S; Lapadula, G; Lichtner, M; Lai, A; Madeddu, G; Malagnino, V; Mondi, A; Mazzotta, V; Nozza, S; Piconi, S; Pinnetti, C; Roldan, E; Rossotti, R; Rusconi, S; Santoro, M; Saracino, A; Spagnuolo, V; Squillace, N; Svicher, V; Taramasso, L; Vergori, A; De Benedittis, S; Fanti, I; Giotta, M; Marelli, C; Rodano', A; Tavelli, A; Cernuschi, M; Cosmaro, L; Perziano, A; Calvino, V; Russo, D; Farinella, M; Policek, N; Negro, V; Augello, M; Carrara, S; Graziano, S; Prota, G; Truffa, S; Vincenti, D; Rovito, R; Sgarlata, M; Giacometti, I; Costantini, A; Barocci, V; Santoro, C; Milano, E; Comi, L; Suardi, C; Badia, L; Cretella, S; Erne, E; Pieri, A; Focà, E; Menzaghi, B; Abeli, C; Chessa, L; Pes, F; Maggi, P; Alessio, L; Nunnari, G; Celesia, B; Vecchiet, J; Falasca, K; Pan, A; Dal Zoppo, S; Segala, D; Bartalesi, F; Costa, C; Ferrara, S; Bassetti, M; Pontali, E; Blanchi, S; Bobbio, N; Borgo, C; Marocco, R; Mancarella, G; Molteni, C; Canavesi, G; Pellicanò, G; Rizzardini, G; Bono, V; Cossu, M; Lolatto, R; Moioli, M; Pezzati, L; Diotallevi, S; Tincati, C; Menozzi, M; Bonfanti, P; Sangiovanni, V; Gentile, I; Esposito, V; Coppola, N; Fusco, F; Di Filippo, G; Rizzo, V; Sangiovanni, N; Martini, S; Cattelan, A; Leoni, D; Cascio, A; Trizzino, M; Francisci, D; Schiaroli, E; Parruti, G; Sozio, F; Messeri, D; Bonelli, S; Lazzaretti, C; Corsini, R; Mastroianni, C; Latini, A; Mastrorosa, I; Lamonica, S; Capozzi, M; Camici, M; Mezzaroma, I; Capparuccia, M; Iaiani, G; Stingone, C; Gianserra, L; Paulicelli, J; Plazzi, M; D'Ettore, G; Fusto, M; Coledan, I; De Vito, A; Fabbiani, M; Montagnani, F; Franco, A; Del Vecchio, R; Di Giuli, C; Orofino, G; Calleri, G; Accardo, G; Tascini, C; Londero, A; Battagin, G; Nicolè, S; Starnini, G; Dell'Isola, S
Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort
2025 De Vito, A; Tavelli, A; Cozzi-Lepri, A; Giacomelli, A; Rossotti, R; Ponta, G; Bobbio, N; Ianniello, A; Cingolani, A; Madeddu, G; Antinori, A; D'Arminio Monforte, A; Bonfanti, P
Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study
2025 Iavarone, M; Alimenti, E; Puoti, M; Hasson, H; Monti, B; Bhoori, S; Peracchi, F; Siribelli, A; Fava, M; Bruccoleri, M; Merli, M; Morsica, G; De Silvestri, A; Bonfanti, P; Castagna, A; Soria, A; Lampertico, P
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort
2025 Vergori, A; Cozzi-Lepri, A; Lo Caputo, S; Tavelli, A; Mazzotta, V; Schiaroli, E; Orofino, G; Mussini, C; Nozza, S; Cingolani, A; Antinori, A; D'Arminio Monforte, A; Bonfanti, P
Lipids and Body Mass Index in Antiretroviral-Experienced People With HIV on Doravirine-Based Treatments: A Comparison Between Dual or Triple Regimen Versus Bictegravir-Based Triple Regimen
2025 Maggi, P; Masiello, A; Menzaghi, B; Sarchi, E; Bellagamba, R; Pellicanò, G; Lagi, F; Cascio, A; Piconi, S; Taramasso, L; Squillace, N; Celesia, B; Pontali, E; Carleo, M; Salomoni, E; Ferrara, S; Madeddu, G; Angioni, G; Rusconi, S; Martini, S; De Socio, G; Falasca, K; Chieffo, G; Bargiacchi, O; Fiordelisi, D; Orofino, G; Ricci, E; Di Biagio, A; Bonfanti, P
Pregnancy in women living with HIV: Experience of IRCCS San Gerardo dei Tintori and a narrative review
2025 Ranzani, A; Lapadula, G; D'Aloia, F; Ornaghi, S; Locatelli, A; Bonfanti, P; Sabbatini, F
Selected comorbidities and the probability of ART switch in PWH with undetectable HIV-RNA: a retrospective analysis in Italy
2025 Cozzi-Lepri, A; Tavelli, A; Taramasso, L; Lapadula, G; Bobbio, N; Piconi, S; Guaraldi, G; Di Biagio, A; Castagna, A; Mazzotta, V; D'Arminio Monforte, A; Bonfanti, P
Persistence of symptoms in long-COVID: follow-up trajectories of 30 symptoms in 755 patients from a national multicenter study from Italy
2025 Floridia, M; Weimer, L; Rovere Querini, P; Bonfanti, P; Lacedonia, D; Figliozzi, S; Zucco, S; Andreozzi, P; Barisione, E; Lo Forte, A; Gnerre, P; Loso, K; Onder, G; Perger, E
Long-term durability of dolutegravir plus darunavir/cobicistat dual regimen in highly antiretroviral-experienced people with HIV (DoDaco study)
2025 Ripamonti, D; Comi, L; Francavilla, A; Valenti, D; Cossu, M; Moschese, D; Lapadula, G; Mezzadri, L; Bonfanti, P; Mazzitelli, M; Cattelan, A; Gulminetti, R; Pagnucco, L; Fabbiani, M; Bini, T; Zazzi, M; Giacomelli, A
Adolescents with Persistent Symptoms Following Acute SARS-CoV-2 Infection (Long-COVID): Symptom Profile, Clustering and Follow-Up Symptom Evaluation
2025 Floridia, M; Buonsenso, D; Macculi, L; Weimer, L; Giuliano, M; Pricci, F; Bianchi, L; Toraldo, D; Onder, G; Perger, E; Parati, G; Bonfanti, P
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile